Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.38 USD | -0.67% | +3.65% | +62.20% |
09/05 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.20% | 47Cr | |
+9.42% | 11TCr | |
+11.84% | 11TCr | |
-2.45% | 2.2TCr | |
-14.15% | 2.19TCr | |
-5.29% | 1.92TCr | |
-4.16% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.24TCr |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Transcript : Larimar Therapeutics, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 05